August Bioservices - End to End (Preclinical to Clinical to Commercial), US-based CDMO Capabilities

August Bioservices can support preclinical research needs as well.These case studies highlight capabilities from cell line development, high-throughput multi-parametric cell health assays, 3D cell culture high content screening, wound healing assays, and mouse models to study colon cancer and lymphoma.In a...

August Bioservices can provide clinical and commercial manufacturing fill finish services - with supporting formulation development, scale up and analytical testing capabilities - across a wide range of injectable products, container sizes and fill volumes.
Vials - from 1/2 mL up to 500 mL
Syringes...

What you need to seamlessly transition from clinical phases to commercial readiness.

Three unique abilities your CDMO must have to complete your project within your timeline are capability, flexibility and availability.


August Bioservices' Director of Customer Operations, Commercial Devel...

August Bioservices has a Binding Technologies Toolbox that is second to none.

These case studies highlight our biophysical characterization capabilities, including the state-of-the-art TRIC (Temperature Related Intensity Change) technology which can provide new insights into protein-small molecule b...

August Bioservices is a US-based CDMO offering end to end outsourced services that support our pharma and biotech clients' projects throughout the drug discovery, development and manufacturing lifecycle.

This piece highlights the company's $65 million expansion investment and the impact on the local...

Watch as 12 months of construction unfolds before your eyes in 30 seconds.

The facility expansion shown here is adding to August Bioservices' Nashville, TN, USA campus:


- 3 new formulation suites
- 2 new filling suites for high-speed vial and PFS lines
- significant warehousing capacity
- redundant utilities
- multi-bay loading dock

August Bioservices is a US-based, sterile injectable CDMO that offers end-to-end fill/finish manufacturing services at the scale you need.

This one page overview summarizes:


- the fill/finish container types, fill volumes and batch sizes August Bio can offer across our multiple, new state-of-the-art filling lines


- the differentiated and value-added capabilities that support our end-to-end services


- the "why" clients choose August Bio
 

August Bioservices, a US-based CDMO, is expanding its current facility and is building a new facility immediately adjacent to its existing building that will house drug discovery, development, formulation, scale up, analytical testing, and clinical and commercial manufacturing - all "under one roof", on one contiguous campus in Nashville, TN.

With a strong focus on sterile injectables and decades of commercialization experience across the leadership team, August Bioservices' manufacturing capabilities can handle a wide range of container sizes and fill volumes.


Vials - 1/2 mL to 500 mL
Bags - 25 mL to 5 L
Syringes - 1/4 mL to 50 mL


As can be seen in this video, August's growth initiatives continue to receive exceptional support from all levels of government and industry in the state of TN.